India to boost production of combat medicines, pharma dept told to prepare list of drugs
New Delhi: India plans to increase the production of combat medicines, including drugs to treat burns, blood replenishers for treatment of trauma injuries such as gunshot wounds, and orthopedic implants.
The Department of Pharmaceuticals has been tasked to come up with a list of such medicines and ensure an increase in their production to mitigate health risk from the ongoing conflict with Pakistan.
Also Read | Health emergency plan introduced for J&K, portable hospitals in Poonch, Uri
The top drug price regulator—National Pharmaceutical Price Regulator (NPPA)—has been directed by the Centre to ensure that the prices of such pharmaceutical items are brought under control.
'The department of pharmaceuticals along with the National Health Systems Resource Centre (NHSRC) is preparing a list of all such medicines used for the treatment of trauma and burn injury, bullet injury and wound etc, so that the production of such pharmaceutical items can be augmented in the country to deal with any health emergency, if needed," said an official familiar with the matter.
Also Read | E-pharmacies, chemists at odds as govt mulls a stop to home delivery of drugs
A decision to this effect was taken at a meeting chaired by the union health minister J.P. Nadda on Friday to review the preparedness of the health sector.
In a war-like situation, health expenditure significantly goes up due to higher demand for medical care, particularly for combat-related injuries and the mental health impacts of conflict.
Medicines and surgical equipment like painkillers, antibiotics, gauges, orthopedic implants, blood replenishers among other products are used for the treatment of trauma injuries, bullet or gunshot wounds, etc.
Also Read | India should permit easier access to over-the-counter medicines
The official added that the top drug regulator has been tasked to review the companies which are manufacturing such products so that they can be and directed to increase the production of such items. 'Similarly, the NPPA has to ensure the price control of these pharmaceutical items."
During the meeting, the government the reviewed the medical preparedness for handling emergency cases, deployment of ambulances; ensuring adequate availability of medical supplies including equipment, medicines, supply of blood vials and consumables; hospital readiness in terms of beds, ICU and HDU; deployment of BHISHM (Bharat Health Initiative for Sahyog, Hita and Maitri) Cubes, advanced mobile trauma care units etc.
'A 24*7 control and command centre is being set up in the health ministry to monitor ongoing efforts and support states in the present times and fulfil the requirements of the state/UT governments," the official said.
A senior doctor from the burns and plastic department at a government hospital said, 'We are ready to tackle any health crisis and we have adequate number of beds, medical supplies etc. In the event of trauma injury or gun shot injury, medicines like painkillers, antibiotics and requirements of blood get increased."
Dr Mahesh Mangal, head of plastic surgery department at Sir Ganga Ram Hospital, said that main war-related injuries are caused by blasts and burns. "A hospital's trauma team comprising plastic surgeons, orthopedic surgeon, neuro surgeon, general surgeon etc, should be capable of saving the life of the patient. Requirement of combat medicine increases during this time—which are life-saving drugs, blood and blood products, fluids, dressings, oxygen, antibiotics and painkillers."
Queries sent to the health ministry spokesperson remained unanswered.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Mint
19 hours ago
- Mint
Health minister Nadda calls for responsive regulatory environment, launches CII Centre for Health
New Delhi: Health minister J.P. Nadda on Thursday called for a unified national effort to strengthen healthcare systems aligned with India's 2047 development roadmap. Speaking at the Confederation of Indian Industry (CII) Annual Business Summit, Nadda stressed on the need for a responsive regulatory environment to ensure the highest standards of quality and safety while underlining India's rise as a hub of pharmaceuticals and medical devices. During the event, the minister launched a CII Centre for Health which will focus on multi-stakeholder collaboration and low-cost innovation in the health sector. He highlighted the government's commitment to healthcare reforms, innovation and accessibility, and called for a more humane, responsive and time-bound regulatory environment, especially in the functioning of key bodies. 'While we must uphold the highest standards of quality and safety, we must also avoid unnecessary delays, red tape must not become a barrier to timely progress,' said the union health minister. 'India's ability to meet global demand—especially during the covid-19 pandemic—as evidence of its growing stature. We moved from being dependent to becoming the dependable,' he added. The CII Centre for Health will focus on multi-stakeholder collaboration, ensuring low-cost innovation in health, streamlining supply barriers, catalyzing the private sector to engage beyond corporate social responsibility, prioritize technical expertise to enable health system strengthening and promote workplace wellness and health as a boardroom agenda. He spoke about the pivotal role of the private sector in driving India's healthcare, and urged AI- and tech-based innovations for enabling mass screenings and telemedicine in India. 'Public-private partnerships can be instrumental in ensuring that early detection and preventive healthcare reach every corner of the country,' the minister added. He urged the industry and all stakeholders to contribute to making India a global benchmark in healthcare by 2047. "Such engagements are critical to nation-building and positioning India as a global leader in health innovation,' he added.
Mint
4 days ago
- Mint
With State hospitals' essential medicine stock less than 40%, Centre sounds alarm bell
New Delhi: India's public health system, a cornerstone for millions, faces a critical shortage of essential medicines and diagnostic services, even as the country grapples with a rising burden of communicable and non-communicable diseases. Several states and Union territories (UTs)–including populous ones such as Uttar Pradesh, Maharashtra, Delhi, Gujarat, West Bengal and Bihar, among many others–have less than 40% levels of essential medicines and diagnostic services available in government-run hospitals and health centres, said an official aware of the matter and as shown by a document reviewed by Mint. At the same time, the Centre has conveyed its unhappiness to states and UTs about consumers being unaware of a key central government scheme to provide free drugs at public healthcare centres. Gaps in implementation A communication from the Union health ministry on 7 May to the states and UTs, seen by Mint, pointed to gaps in the implementation of its FDSI (free drugs and diagnostics service initiative) program under the national health mission (NHM). 'These include gaps in the notification by state of the average number of drugs and diagnostics available across facilities, as compared to the recommended numbers outlined in the National Essential Drugs and Diagnostics Lists as per IPHS (Indian Public Health Standards)," the communication noted, adding that there is also a noticeable gap between data reported in state reports and data updated in the government's monitoring dashboard. However, the official cited above, who spoke on the condition of anonymity, said the matter of data gap is not worrisome. 'The states/UT governments have to update the data on the government's portal for effective monitoring and evaluation of FDSI," this person said. 'This is not a big issue; (it is) a regular matter." Also read | India's first public health university on the cards At present, a diagnostic module is being piloted in the DVDMS (drugs and vaccines distribution management system) to monitor the availability of diagnostic reagents and consumables. The DVDMS is an IT application that facilitates the implementation of the FDSI and improves the supply chain of drugs, sutures, and surgical items for district drug warehouses across India. The health ministry has now told states and UTs to update their lists of essential drugs and diagnostic tools to match national guidelines. They also need to evaluate their specific needs and provide feedback on any drug or diagnostic service. Queries emailed to the office of Union health minister J.P. Nadda, health secretary Punya Salila Srivastava, and health ministry spokesperson remained unanswered till press time. Prof Dr K Srinath Reddy, former, President of Public Health Foundation of India (PHFI): 'Availability of essential drugs and diagnostics at all public healthcare facilities is pivotal for meeting both major indicators of universal health coverage, which are financial protection and service coverage. Drugs and diagnostics contribute to a very high level of out of pocket expenditure, resulting in financial hardship to those who need healthcare, especially for chronic conditions. Health outcomes will be poor if healthcare providers are handicapped by absence of essential drugs and diagnostic aids. All efforts must be made by state and central governments to urgently fill these gaps." What are the minimum thresholds? The Centre has been trying to implement the Indian Public Health Standards (IPHS) 2022 guidelines to provide uniform, high quality health services across all states. IPHS are essential benchmarks that ensure the delivery of minimum essential services through public healthcare facilities, including district hospitals, sub-district hospitals, community health centers, primary health centers, and sub health centres. In 2015, the Union health ministry launched the FDSI to provide free essential medicine at all public health facilities, with an aim to reduce out-of-pocket expenditure (OOPE). Both the marquee initiatives are being implemented under the National Health Mission (NHM) to achieve Universal Health Coverage (UHC), providing equitable, affordable and quality healthcare. Also read | Need thorough virtual checkups of public health facilities, Centre tells states According to the guidelines, a district hospital should have at least 375 essential medicines such as anti-infectives, cardiovascular medicines, anti-diabetic medicines, antidepressants, pain relievers, antineoplastic drugs, vitamin and mineral supplements, anticonvulsants, etc. A sub-district hospital needs to stock 325 medicines, community health centres 299 medicines, primary health centres at least 171 medicines, and sub-health centres need to store 105 medicines. As for free diagnostic services, a district hospital should have at least 134 diagnostic services, sub-district hospital (111), community health centre (97), primary health centre (63) and a sub-health centre must provide 14 services. Where are the gaps? According to information reviewed by Mint, states and UTs that have been red flagged by the Centre for having less than 40% availability of medicines as on 25 April 2025 are: Chhattisgarh, Kerala, Maharashtra, Mizoram, Nagaland, Punjab, Arunachal Pradesh, Assam, Bihar, Dadra and Nagar Haveli and Daman and Diu (DNHⅅ), Delhi, Gujarat, Haryana, J&K, Jharkhand, Manipur, Meghalaya, Rajasthan, Sikkim, Uttar Pradesh, Uttarakhand and West Bengal. Also read | Cell planned to find treatments and vaccines for future pandemics Further, the following have less than 40% availability of diagnostic services at the government health facilities: Andaman & Nicobar Island, Arunachal Pradesh, Assam, Bihar, Chhattisgarh, Delhi, DNHⅅ, Kerala, Maharashtra, Mizoram, Nagaland, Punjab, Assam, Bihar, DNHⅅ, Delhi, Goa, Gujarat, Haryana, Himachal Pradesh, Jammu & Kashmir, Jharkhand and Karnataka, Ladakh, Lakshadweep, Madhya Pradesh, Maharashtra, Manipur, Meghalaya, Nagaland, Odisha, Puducherry, Punjab, Rajasthan, Sikkim, Uttar Pradesh, Uttarakhand and West Bengal Getting the message across The Centre has also raised concerns about common citizens and local public representatives often remaining unaware of FDSI, which limits their ability to fully utilize these essential services. The health ministry has directed the states and UTs to develop comprehensive strategies to promote awareness campaigns, and mandatory display of available drugs and diagnostic services at all health facilities. Dr Rajeev Jayadevan, public health expert & former past president, Indian Medical Association (IMA), Cochin Chapter, remarked that despite its goal to provide essential medicines and tests free of cost at public health facilities, many citizens — even in urban areas — apparently remain unaware of these entitlements. Also read | NMC asks medical institutions to establish dedicated Tobacco Cessation Centres 'This has resulted in a gap between planning and implementation," Jayadevan said. 'Limited public awareness and logistical hurdles are major barriers. While media coverage, posters and displays can improve visibility, real impact requires trained personnel, accurate data reporting, and digital integration via systems like DVDMS. Health equity starts with access — and access begins with awareness, supported by reliable systems that deliver."
Time of India
14-05-2025
- Time of India
Raj to link med distribution with health records via iHMS integration
1 2 Jaipur: The state govt currently operates e-Aushadhi, a portal dedicated to the free distribution of medicines. However, the system is not linked to patients' Ayushman Bharat Health Account (ABHA) IDs, limiting the creation of comprehensive electronic health records (EHRs). At present, only 1.2 crore ABHA cards in Rajasthan are connected to EHRs. To bridge this gap, the govt plans to integrate medicine distribution with the Integrated Health Management System (iHMS), enabling real-time EHR generation alongside drug dispensation.A senior health department official said, "We are finding solutions and taking measures to generate EHR and link them with patients' ABHA ID so that the patient could access all their health records, including pharmacy and treatment. "The health department generated 6.2 crore ABHA for the people of the state, but out of those, just 1.2 crore ABHAs are linked with EHRs. ABHA integrates EHRs to facilitate the storage and retrieval of patient information. If ABHA is not linked with EHR, then ABHA are just mere numbers. ABHA is a unique 14-digit number used to link all the health records of a of 1.2 crore EHRs generated in the state, 68.6 lakh EHRs were generated using Co-win records (Covid-19 vaccination) during the Covid-19 pandemic. Besides, 34 lakh EHRs were generated using a private pharma limited, and the rest by using other platforms. Despite that, just 1.2 crore EHRs were state govt is using the state govt's iHMS (integrated health management system) for generating ABHA cards and EHRs. Through iHMS, 1.9 crore ABHAs were generated, but just 46,095 EHRs were generated using iHMS. A senior health department official said, "We are taking measures to increase the EHRs so that people can use their health records stored electronically while going for doctor's consultation or for treatment."The health department is taking measures to make use of iHMS to generate EHRs. iHMS is being used in govt hospitals for the registration of patients and other works, including admission and discharge of patients. The state govt is generating EHRs daily, said the official. On Tuesday, 77,150 EHRs were health department advocates that linking all healthcare reports, prescriptions, and lab test reports in one place eliminates the requirement to carry hard copies of reports while visiting a healthcare provider. ABHA helps in easy access and tracking of health records.
